Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Recognizing CVG can help diagnose systemic amyloidosis early.

The gels improved wound healing in diabetic mice but need human trials.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.

Fluralaner topical spot-on successfully treated a cat's hair shedding and scales caused by Demodex gatoi.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Belimumab may cause hair loss in lupus patients.

Patients need better information about the risks of long-term steroid use.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Glutamic acid microneedle patches promote better hair growth than traditional treatments.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

The patient had paraneoplastic pemphigus without mucosal involvement.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Sabal serrulata and biomimetic peptides with microneedling reduced hair loss and improved hair thickness in men with balding.

Ganoderma lucidum may help treat enlarged prostate in rats.

Monoclonal antibodies are often linked to alopecia areata cases.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Curcumin-primed milk vesicles may help treat hair loss by promoting hair growth.

A dissolving microneedle patch with collagen XVII effectively promotes hair regrowth in androgenic alopecia.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Cervi Parvum Cornu complex improved urinary symptoms in men without major side effects.